Navigation Links
GDS International Leads the Way for the Pharmaceutical Industry at its Upcoming NGP DD 30 Summit in Madrid
Date:6/12/2013

MADRID, June 12, 2013 /PRNewswire/ --

On 9th - 11th September, a selection of the region's most prominent C-level executives from across the pharmaceutical industry will convene at the Sheraton Mirasierra Hotel & Spa, Madrid at GDS International's fifth European Next Generation Pharmaceutical Drug Discovery Summit.

This year NGP DD 30 has elected 30 of the most well-respected decision makers from the pharmaceutical sector to meet, network, and assess the rapidly evolving industry in a vibrant, closed door environment at the 2.5 day event.

The exclusive location, the intimate number of delegates and the outstanding content offer the executives an ideal structure for new business relationships to grow. The series of interactive workshops and moderated peer-led panel discussions give delegates the opportunity to meet with business analysts and solution providers to determine strategies and solutions for the year ahead.

Included within this year's delegation are Sibo de Jong, Vice-President Pharmaceutical R&D, Astellas; Simon Read, Vice President & Head of Global Biomedical Sciences, Andreas Schneider, VP Life Science Alliances, Roche; Michael Rotte, Biomarker Development EU Head, Novartis; Dave Gunput, Head of Translational Medicine & Exploratory Development, Mitsubishi Pharmaceutical.

The industry is facing its biggest ever challenges. With the help of all involved the summit will highlight the most relevant areas in today's market. Topics to be discussed at this year's summit include; Personalizing Medicine, Slip Streaming the R&D Process & Reducing Late Stage Attrition.

Bjorn Mellgard, Global Head of Translational Medicine Gastrointestinal, Novartis attended last year's summit, and said: 'The quality of the discussions and the quality of the attendees has been really valuable. Highly relevant topics and overall, above my expectations" he added, "it was a really worthwhile investment - it's really been good to be here".

The summit aims to provide the perfect environment for key decision makers to network and collaborate with their peers, discuss organizational strategies for the future and establish meaningful working relationships with a dynamic selection of delegates, vendors and sponsors. Offering an alternative to the traditional conference format, the summits provide true innovation and value for money.

Charlotte Wright, Summit Director at GDS International, the global business event company behind NGP DD, says, "The Industry and Academia need to work alongside each other and become more open with the sharing of information if this Industry is to move forward, which I feel is where the Next Generation Pharmaceutical Drug Development 30 (NGP DD 30) comes into play. The NGP DD 30 summit brings together 30 Senior Level executives from within the Industry to network and mind share with their peers. We offer our executives an exciting opportunity to dissect the industry, share personal experiences and come up with best practices moving forward. I for one thoroughly look forward to the discussions and seeing the outcomes at the event in September. No doubt this will once again be a fantastic event!"

For more information, please visit http://www.pharmasummiteurope.com

About GDS International

GDS International creates engagement opportunities for business, onsite and online. We bring senior executives together, face-to-face, at exclusive summits, conferences, and on virtual private roundtables to advance their business with brilliant results. We create tangible business opportunities: networking platforms that help to establish thought leaders, stay in touch with existing partners, and stay abreast of crucial market, technology and regulatory developments. We're almost 20 years old. Our headquarters are based in Bristol, UK, with subsidiaries offices in New York, Miami and Sydney. 

For more information about GDS International or any of its many products please visit http://www.gdsinternational.com 

Contact & press partnerships information:
Charlie Bestall, Summit Marketing Manager
charlie.bestall @gdsinternational.com
+44-(0)117-921-2754


'/>"/>
SOURCE GDS International
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. RSB Spine, LLC, Announces International Distribution and Licensing Agreement
2. PAREXEL International To Present At William Blair Growth Stock Conference And Goldman Sachs Healthcare Conference
3. MEDIFIRST SOLUTIONS, INC. To Exhibit At The Orlando International Beauty Show
4. DMH International Announces EMR Integration to TouchPACS
5. International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
6. Israel Brain Technologies Announces Israels 1st International Brain Technology Conference
7. Clinical Team Researching the Impact of the EarlySense System Wins Best Novel Idea Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference
8. PAREXEL International To Present At Jefferies Healthcare Conference
9. Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis
10. IsoRay Announces A New International Distributor For Greece
11. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
Breaking Medicine News(10 mins):